Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Keming Capsule
- Development stage
- Phase 3
- Lead developer
- Jinan Kangzhong Pharmaceutical Technology Development
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Administration
- Oral
01
Overview
Keming Capsule is a Traditional Chinese Medicine (TCM) developed by Jinan Kangzhong Pharmaceutical Technology Development for the treatment of post-infectious cough (PIC). It is specifically formulated for patients exhibiting the TCM pattern of "yang deficiency and cold invading lung" (阳虚寒袭肺证). The therapeutic rationale involves warming the lungs and dispersing cold to alleviate persistent coughing following a respiratory infection. As of 2024, the drug is in Phase III clinical development in China, evaluated in a multicenter, randomized, double-blind, placebo-controlled trial (CTR20240031) to assess its efficacy and safety, with the primary endpoint being the cough resolution rate measured by the Visual Analogue Scale (VAS).
- Brand names
- Keming Capsule
- Other names
- 克明胶囊Keming Jiaonang
02
Targets
RELA (Nuclear Factor Kappa B Subunit p65)STAT3 (Signal Transducer and Activator of Transcription 3)TLR4 (Toll-like receptor 4)TRPA1 (Transient receptor potential cation channel subfamily A member 1)TRPV1 (Transient receptor potential cation channel subfamily V member 1)
Beyond the preview
Go deeper on Keming Capsule.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Keming Capsule.